Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Rivaroxaban 10 mg tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10x14
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Rivaroxaban 10 Tablet is an oral anticoagulant belonging to the class of direct Factor Xa inhibitors. It works by selectively inhibiting Factor Xa, a key enzyme in the blood coagulation cascade, thereby reducing the risk of blood clot formation. This medication provides predictable anticoagulant effects with minimal need for routine monitoring, making it a convenient option for patients at risk of thromboembolic events.
Possible side effects include bleeding (such as nosebleeds, gastrointestinal bleeding, or bruising), headache, dizziness, and nausea. Serious but rare side effects may include liver enzyme elevations and hypersensitivity reactions. Bleeding risks are increased in patients with renal impairment or concurrent use of other anticoagulants or antiplatelets.
Rivaroxaban 10 mg Tablet is indicated for the prevention of venous thromboembolism (VTE) in patients undergoing elective hip or knee replacement surgery. It is also used for the treatment and secondary prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in appropriate clinical settings, as directed by a healthcare provider.
Use only under medical supervision. Not recommended for patients with active bleeding, severe hepatic impairment, or those with prosthetic heart valves. Dose adjustments may be required based on kidney function. Avoid abrupt discontinuation unless directed by a physician, as it may increase the risk of thrombotic events.
Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.
Composition : Rivaroxaban 15 mg tablet
Composition : Rivaroxaban 20 mg tablet
Composition : Prasugrel 10 mg Tablets
Composition : Ramipril 1.25 mg tablet
Composition : Ramipril 2.5 mg tablet
Composition : Ramipril 5 mg tablet
Composition : Olmesartan Medoxomil (40mg) tablet
Composition : Olmesartan 20 mg + Hydrochlorothiazide 12.50 mg tablet
Composition : Olmesartan 40 mg + hydrochlorothiazide 12.50 mg tablet
Composition : Nitroglycerine 6.4 mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Rivaroxaban 10 mg Tablet is an oral anticoagulant (blood thinner) used for the prevention and treatment of blood clots, deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke prevention in high-risk cardiovascular patients. It works by selectively inhibiting Factor Xa, reducing clot formation. This makes it a key product in the cardiology, vascular care, and anticoagulation therapy segment, with strong demand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from cardiologists, physicians, orthopedic surgeons, and hospitals. Anticoagulant therapy is widely used in both acute and long-term management, ensuring steady prescriptions, repeat purchases, and strong institutional demand, making it a high-value product in the pharmaceutical portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiology and anticoagulation segment with monopoly rights, quality manufacturing standards, attractive promotional support, and reliable supply chain assistance for distributors and franchise partners.
Wholesalers and distributors benefit from high prescription volume, strong hospital usage, long-term patient therapy needs, and increasing awareness of clot prevention in cardiovascular care, making this product a profitable and sustainable addition to their pharmaceutical business when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in cardiology and anticoagulation formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, promotional support, and PCD pharma franchise opportunities in the cardiac segment.